On behalf of the Canadian Arthritis Patient Alliance (CAPA), we welcomed the opportunity to provide feedback on the draft guidance for biosimilar biologic drugs. Ensuring that patient perspectives are included in the development of policies is essential to improving...
In 2014, the Arthritis Alliance of Canada (AAC), a former nationwide coalition of more than thirty-five groups including people living with arthritis, health care professionals, researchers, funding agencies, government, voluntary sector agencies and industry...
We would like to thank all participants of the CAPA Webinar on Disability Tax Credit (DTC) that was hosted by the Canada Revenue Agency representatives on Saturday, October 24, 2020. Participants were able to learn about eligibility criteria and how to apply for these...
Bill C-17 amends the Food and Drugs Act, which hasn’t been substantially updated in over 50 years. It was introduced to the House of Commons by the Minister of Health in December 2013. The Bill has two main goals: Strengthen safety oversight of therapeutic products...
Pain is the hallmark symptom of the various forms of arthritis. We’ve been involved in advocating on issues relating to arthritis pain, such as the federal action plan on opioids and the Chronic Pain Research Network. Health Canada information about Opioids...
English 
Français du Canada